SCHEMBL16186705

SCHEMBL16186705

c1ccc(-c2cccc(N3c4cc(-c5ccccc5)ccc4C4(c5ccccc5Oc5ccccc54)c4cc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)ccc43)c2)cc1

nearest known ligand 0.33

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.33
FAAH O00519 1/20 0.33
HSP90AA1 P07900 1/20 0.33
PKM P14618 1/20 0.33
HTT P42858 1/20 0.33
ATM Q13315 1/20 0.33
MGLL Q99685 1/20 0.33
DHFR P00374 1/20 0.32
HPSE Q9Y251 2/20 0.32
GRM5 P41594 1/20 0.31
BACE1 P56817 1/20 0.31
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
KMT2A Q03164 2/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16186678 0.96 ALDH1A1 (0.35) ALDH1A1FAAHHSP90AA1PKMHTT
SCHEMBL15030882 0.95 MEN1 (0.34) ALDH1A1FAAHHSP90AA1PKMHTT
SCHEMBL16186706 0.94 BACE1 (0.31) ALDH1A1BACE1MEN1MAPTHPGD
SCHEMBL15030883 0.91 FAAH (0.37) ALDH1A1FAAHHSP90AA1PKMHTT
SCHEMBL15030762 0.90 MEN1 (0.36) ALDH1A1FAAHHSP90AA1PKMHTT
SCHEMBL15030671 0.90 FAAH (0.36) ALDH1A1FAAHHSP90AA1PKMHTT
SCHEMBL15030884 0.89 MEN1 (0.33) ALDH1A1BACE1MEN1MAPTHPGD
SCHEMBL15030880 0.89 MEN1 (0.35) ALDH1A1FAAHMGLLBACE1MEN1
SCHEMBL15030761 0.88 MEN1 (0.34) ALDH1A1FAAHMGLLBACE1MEN1
SCHEMBL16186673 0.88 MEN1 (0.35) ALDH1A1FAAHMGLLBACE1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices MERCK PATENT GMBH (DE) 2019-05-28 US disclosed
EP-2780325-B1 SPIRO-DIHYDROACRIDINE DERIVATIVES AND THEIR USE AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2016-02-03 EP disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 US disclosed
US-20140316134-A1 SPIRO DIHYDROACRIDINE DERIVATIVES AND THE USE THEREOF AS MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2014-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10305040-B2 Spiro dihydroacridine derivatives and the use thereof as materials for organic electroluminescence devices SORD, ALDH1A1, SDHA ALDH1A1 2/4885FAAH 4733/4885HSP90AA1 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.